November 11, 2025

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Biotech Growth with Over 30% Potential Upside

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is making waves in the biotechnology sector with a promising portfolio of dermatological treatments and a market capitalization of $2.91 billion...

Azenta, Inc. (AZTA) Stock Analysis: Navigating the 16.22% Upside Potential in the Healthcare Sector

For investors seeking opportunities within the healthcare sector, Azenta, Inc. (NASDAQ: AZTA) presents a compelling case with its unique positioning in the medical instruments and supplies..

Evotec SE (EVO) Stock Analysis: Navigating a Potential 83% Upside in the Healthcare Sector

Evotec SE (EVO), a prominent player in the drug discovery and development sector, is garnering attention from investors as its stock currently trades at $2.99 on..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 50% Upside Potential for Investors

Perrigo Company plc (NYSE: PRGO), a stalwart in the healthcare sector, commands attention with its diverse portfolio of over-the-counter health and wellness solutions. Headquartered in Dublin,..

Mesoblast Limited (MESO): Investor Outlook on a 130% Potential Upside in the Biotech Sector

Investors eyeing the biotechnology sector may find Mesoblast Limited (NASDAQ: MESO) a compelling option, especially given its substantial market capitalization of $1.95 billion and promising potential..

Disc Medicine, Inc. (IRON): Analyst Consensus Points to 33% Upside for This Biotech Innovator

Disc Medicine, Inc. (NASDAQ: IRON) is capturing the attention of investors with its strategic focus on addressing serious hematologic diseases through innovative biopharmaceutical solutions. As a..

Warby Parker Inc. (WRBY): Investor Outlook Highlights 31.30% Potential Upside

Warby Parker Inc. (NYSE: WRBY) is a prominent player in the eyewear industry, strategically positioned within the healthcare sector under the medical instruments and supplies category...

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Unveiling a 163% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands out in the biotechnology sector with its focus on developing treatments for rare and ultra-rare genetic diseases. With a current..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Biotechnology Innovator with 122.82% Potential Upside

Vera Therapeutics, Inc. (NASDAQ: VERA), a promising player in the biotechnology sector, has captured investor interest with its potential for substantial upside. As a clinical-stage company,..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Healthcare Diagnostics Landscape with a 27.74% Potential Downside

GRAIL, Inc. (NASDAQ: GRAL) stands at the forefront of the healthcare diagnostics industry, specializing in multi-cancer early detection testing and services. Headquartered in Menlo Park, California,..

Certara, Inc. (CERT) Stock Analysis: Exploring a 61.83% Potential Upside in the Healthcare Sector

Investors eyeing the healthcare sector might find Certara, Inc. (NASDAQ: CERT) an intriguing prospect, especially considering its significant potential upside of 61.83%. With a market cap..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a Potential 111.60% Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a burgeoning player in the biotechnology industry, is making waves with its innovative eye-care therapies. With a market capitalization of $2.31..

Edgewise Therapeutics, Inc. (EWTX) Investor Outlook: Exploring a Potential 98% Upside

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a burgeoning player in the biotechnology sector, offers intriguing opportunities for investors with its promising pipeline of therapies targeting muscle disorders...

Novavax, Inc. (NVAX) Stock Analysis: Navigating a Potential 81% Upside in Biotech

Novavax, Inc. (NASDAQ: NVAX), headquartered in Gaithersburg, Maryland, is a prominent player in the biotechnology sector, with a focus on developing innovative vaccines to combat serious..

ImmunityBio, Inc. (IBRX) Stock Analysis: A 372% Potential Upside in the Biotech Sector

ImmunityBio, Inc. (NASDAQ: IBRX) is capturing the attention of investors in the healthcare sector, particularly within biotechnology, thanks to its promising growth potential. With a market..

Veracyte, Inc. (VCYT) Stock Analysis: Riding the Diagnostics Wave with a 6.97% Upside

Veracyte, Inc. (NASDAQ: VCYT) stands at the forefront of the diagnostics and research industry, offering innovative genomic solutions that are reshaping cancer diagnostics. Headquartered in South..

Liquidia Corporation (LQDA) Stock Analysis: Exploring Growth Potential with a 54.89% Upside

Liquidia Corporation (NASDAQ: LQDA) is capturing the attention of investors in the biotechnology sector, driven by its significant growth potential and strategic focus on addressing unmet..

GeneDx Holdings Corp. (WGS) Stock Analysis: A 9.54% Upside in the Surging Genomics Market

GeneDx Holdings Corp. (NASDAQ: WGS) stands at the forefront of the genomics industry, carving out a niche in diagnostics and research, with a particular emphasis on..

PACS Group, Inc. (PACS) Stock Analysis: A 177% Upside Potential in the Healthcare Sector

PACS Group, Inc. (PACS) is emerging as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. Based in Farmington, Utah, the..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a 116% Potential Upside

Investors looking for high-risk, high-reward opportunities in the biotechnology sector may find Beam Therapeutics Inc. (NASDAQ: BEAM) an intriguing prospect. With a market capitalization of $2.2..

Search

Funds

November 11, 2025

Search

Funds

November 11, 2025

FTSE 100

Funds